Reply to the letter from Manferdelli et al.: ‘Muscle O2 diffusion capacity by NIRS: a new approach in the air

By sjmartinez • December 3, 2022

Pilotto AM, Adami A, Mazzolari R, Brocca L, Crea E, Zuccarelli L, Pellegrino MA, Bottinelli R, Grassi B, Rossiter HB, Porcelli S. Reply to the letter from Manferdelli et al.: 'Muscle O₂diffusion capacity by NIRS: a new approach in the air'. J Physiol. 2022 Dec;600(23):5165-5166. doi: 10.1113/JP283919. Epub 2022 Nov 19. PMID: 36335427.

Tags: Harbor UCLA, muscle oxidative capacity, NIRS, O2 diffusing capacity, Publications, Pulmonary, Critical Care & Sleep Medicine, Reliability

Chronic obstructive pulmonary disease and the risk for myocardial infarction by type in people with HIV

Crothers K, Nance RM, Whitney BM, Harding BN, Heckbert SR, Budoff MJ, Mathews WC, Bamford L, Cachay ER, Eron JJ, Napravnik S, Moore RD, Keruly ...

Calcium intake and lung cancer risk: a pooled analysis of 12 prospective cohort studies

Takata Y, Yang JJ, Yu D, Smith-Warner SA, Blot WJ, White E, Robien K, Prizment A, Wu K, Sawada N, Lan Q, Park Y, Gao ...

Combination of pioglitazone, a PPARγ agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung injury in adult mice lung explants

Kurihara C, Sakurai R, Chuang TD, Waring AJ, Walther FJ, Rehan VK. Combination of pioglitazone, a PPARγ agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung ...